EUROAPI is an API manufacturer based in France. It holds 48 active US drug master files and 53 valid CEPs. Its filings concentrate with MINSA (CR) and NCELS (KZ). Its GMP standing is certified by ANSM (FR), EDQM and ZLG (DE), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 4 March 2022 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Frankfurt am Main, Germany | Not on file |
| Frankfurt, Germany | Not on file |
| Germany, Germany | 3020754015 |
| Paris, France | Not on file |
| France, France | 0000001463 |
| Saint-Aubin-lès-Elbeuf, France | Not on file |
8 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Hydrocortisone | EDQM, SFDA (Saudi Arabia), US FDA | 9 |
| Dexamethasone | EDQM, SFDA (Saudi Arabia), US FDA | 8 |
| Prednisolone | EDQM, US FDA | 7 |
| Methylprednisolone | EDQM, SFDA (Saudi Arabia), US FDA | 6 |
| Alprostadil | EDQM, SFDA (Saudi Arabia), US FDA | 4 |
| Clobazam | EDQM, SFDA (Saudi Arabia), US FDA | 4 |
| Hydroxocobalamin | EDQM, US FDA | 4 |
| Cyanocobalamin | EDQM, US FDA | 3 |
| Glimepiride | EDQM, US FDA | 3 |
| Norepinephrine | EDQM, SFDA (Saudi Arabia) | 3 |
| Bimatoprost | SFDA (Saudi Arabia), US FDA | 2 |
| Furosemide | EDQM, US FDA | 2 |
| Irbesartan | EDQM, US FDA | 2 |
| Ketoprofen | EDQM, US FDA | 2 |
| Latanoprost | EDQM, US FDA | 2 |
| Prednisone | EDQM, US FDA | 2 |
| Ramipril | EDQM, US FDA | 2 |
| Selegiline | EDQM, US FDA | 2 |
| Spironolactone | EDQM, US FDA | 2 |
| Apomorphine | US FDA | 1 |
| Buserelin | EDQM | 1 |
| Carboprost | US FDA | 1 |
| Ciclopirox | EDQM | 1 |
| Ciclopirox Olamine | EDQM | 1 |
| Deflazacort | EDQM | 1 |
| Desoximetasone | US FDA | 1 |
| Dinoprost | EDQM | 1 |
| Dinoprostone | US FDA | 1 |
| Fexofenadine | EDQM | 1 |
| Fluorometholone | US FDA | 1 |
| Fluticasone Propionate | EDQM | 1 |
| Gonadorelin | EDQM | 1 |
| Hydroxychloroquine | US FDA | 1 |
| Iloprost | US FDA | 1 |
| Leflunomide | US FDA | 1 |
| Levomepromazine Maleate | EDQM | 1 |
| Levomethadone | EDQM | 1 |
| Metamizole | EDQM | 1 |
| Nadolol | EDQM | 1 |
| Nalbuphine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 24 | None |
| NCELS (KZ) | 1 | None |
| ANSM (FR) | None | 88 |
| EDQM | None | 26 |
| ZLG (DE) | None | 4 |
| ANVISA (Brazil) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $475.8M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. EUROAPI comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.